What is a stock summary page? Click here for an overview.
Business Description
VeriTeQ Corp
NAICS : 339112
SIC : 3841
ISIN : US9234491028
Compare
Compare
Traded in other countries / regions
ATL2.Germany Description
VeriTeQ Corp develops and markets RFID technologies to identify implantable medical devices to use in radiation therapy treatment. The company is building a data analytics and informatics platform that will collect non-patient specific treatment regimen data and improve evidence-based healthcare.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -17.04 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -63.13 | |||||
Beneish M-Score | -123.66 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Days Inventory | 15.47 | |||||
Days Sales Outstanding | 1.1 | |||||
Days Payable | 391.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.8 | |||||
Operating Margin % | -204.23 | |||||
Net Margin % | -510.54 | |||||
FCF Margin % | 65.89 | |||||
ROA % | -2416.29 | |||||
ROC (Joel Greenblatt) % | -4128.13 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.05 | |||||
EV-to-Revenue | 4.15 | |||||
Price-to-Median-PS-Value | 0.8 | |||||
Earnings Yield (Greenblatt) % | -106.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VeriTeQ Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | -1.835 | ||
EPS (TTM) (€) | - | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | - | ||
14-Day RSI | - | ||
14-Day ATR (€) | - | ||
20-Day SMA (€) | - | ||
12-1 Month Momentum % | - | ||
52-Week Range (€) | 0.01 - 4.3 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
VeriTeQ Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
VeriTeQ Corp Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
VeriTeQ Corp Frequently Asked Questions
What is VeriTeQ Corp(FRA:ATL2)'s stock price today?
The current price of FRA:ATL2 is €0.04. The 52 week high of FRA:ATL2 is €4.30 and 52 week low is €0.01.
When is next earnings date of VeriTeQ Corp(FRA:ATL2)?
The next earnings date of VeriTeQ Corp(FRA:ATL2) is .
Does VeriTeQ Corp(FRA:ATL2) pay dividends? If so, how much?
VeriTeQ Corp(FRA:ATL2) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |